Long term effects of amlodipine on renal haemodynamics and microalbuminuria in patients with essential hypertension

Clinical Drug Investigation

Volumn 13, Issue SUPPL. 1, 1997, Pages 36-41

  Perinotto, Patrizia ^a   Ragni, Giorgio ^a   Serventi, Michele ^a   Giberti, Daniela ^a   Tateo, Enrico ^a   Calzolari, Massimo ^a   Giucastro, Giuliano ^a   Buzio, Carlo ^a   Montanari, Alberto ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ALBUMIN; AMLODIPINE; CALCIUM ANTAGONIST;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VASODILATATION;

EID: 0030750262     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700131-00008     Document Type: Article

References (26)

1. Loutzenhiser R, Epstein M. Calcium antagonists and the kidney. Hosp Pract 1987; 22: 63-76
2. Loutzenhiser R, Epstein M. Renal hemodynamic effects on calcium antagonists. In: Epstein M, Loutzenhiser R, editors. Calcium antagonists and the kidney. Philadelphia: Hanley & Belfus, 1990: 33-74
3. Zanchetti A, Leonetti G. Natriuretic effect of calcium antagonists. J Cardiovasc Pharmacol 1985; 7 Suppl. 4: S33-7
4. Romero S, Raij L, Granger JP, et al. Multiple effects of calcium entry blockers on renal function in hypertension. Hypertension 1987; 10: 140-51
5. Montanari A, Ragni G, Vallisa D, et al. Role of blood pressure in the natriuretic response to acute calcium channel blockade in humans. J Cardiovasc Pharmacol 1991; 17: 724-30
6. Montanari A, Vallisa D, Ragni G, et al. Abnormal renal responses to calcium entry blockade in normotensive offspring of hypertensive parents. Hypertension 1988; 12: 498-505
7. Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar response to ANGII. Am J Physiol 1989; 256: F1015-20
8. Carmines PK, Mitchell KD, Navar LG. Effects of calcium antagonists on renal hemodynamics and glomerular function. Kidney Int 1992; 41 Suppl. 36: 43-8
9. Mimran A, Insua A, Ribstein J, et al. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic neuropathy. Diabetes Care 1988; 11: 850-3
10. Holdaas H, Hartmann A, Lien MG, et al. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular-transport functions in insulin dependent diabetics with nephropathy. J Intern Med 1991; 229: 163-70
11. Michisch O, Schmid M, Mann JFE, et al. Calcium Antagonisten by chronischer Niereninsuffizienz. Dtsch Med Wochenschr 1988; 113: 1546-8
12. Yudkin JS, Porrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 1988; 2: 530-3
13. Haffner SM, Stern MP, Gruber MK, et al. Microalbuminuria: potential marker for increased cardiovascular risk factors in non-diabetic subjects? Arteriosclerosis 1990; 10: 727-31
14. Ljungman S. Microalbuminuria in essential hypertension. Am J Hypertens 1990; 3: 956-60
15. Erley CM, Haefele U, Meyne N, et al. Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs. Hypertension 1993; 21: 810-5
16. Fleckenstein A, Frey M, Zorn J, et al. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile. Am J Cardiol 1989; 64: 211-341
17. Schnurr E, Lahmf W, Kuppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol 1980; 13: 26-9
18. Smith HW, Goldring W, Chasis H. The measurement of the tubular excretory mass effective blood flow and filtration rate in the normal human kidney. J Clin Invest 1938; 17: 263-78
19. Montagna G, Buzio C, Calderini C, et al. Relationship of proteinuria and albuminuria to posture and urine collection period. Nephron 1983; 35: 143-4
20. Reams GP, Lau A, Mamory A, et al. Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state. Am J Kidney Dis 1987; 10: 446-51
21. Hulthen UL, Katzman PL. Renal effects of acute and long-term treatment with felodipine in essential hypertension. J Hypertens 1988; 6: 231-7
22. Reams GP, Bauer JH. Acute and chronic effects of calcium antagonists on the essential hypertensive kidney. In: Epstein M, Loutzenhiser R, editors. Calcium antagonists and the kidney. Philadelphia: Hanley & Belfus, 1990: 247-56
23. Bianchi S, Bigazzi R, Baldari G, et al. Microalbuminuria in patients with essential hypertension: effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker. Am J Hypertens 1991; 4: 291-6
24. Lenz T, August P. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure. Wien Klin Wochenschr 1990; 102: 315-9
25. Persson B, Andersson OK, Wysocki M, et al. Calcium antagonism in essential hypertension: effect on renal hemodynamics and microalbuminuria. J Intern Med 1992; 231: 247-52
26. Dworkin LD, Benstein JA. Antihypertensive agents, glomerular hemodynamics and glomerular injury. In: Epstein M, Loutzenhiser R, editors. Calcium antagonists and the kidney. Philadelphia: Hanley & Belfus, 1990: 155-76